Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Neurocrine Biosciences, Inc. shareholders
As of Sep 30, 2026, 758 institutions reported holding Neurocrine Biosciences, Inc. Largest: BlackRock, Vanguard and Dodge & Cox. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Neurocrine Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 14.9M | +1.14M | Nov 13, 2026 | |
| Vanguard | 10.4M | +135K | Nov 16, 2026 | |
| Dodge & Cox | 5.5M | −80,129 | Nov 13, 2026 | |
| JPMorgan | 5.29M | −1.11M | Nov 12, 2026 | |
| State Street | 4.81M | +422K | Nov 12, 2026 | |
| AQR Capital Management LLC | 3.06M | −756K | Nov 16, 2026 | |
| Vestal Point Capital, LP | 2.5M | +620K | Nov 16, 2026 | |
| Renaissance Technologies | 2.3M | −35,200 | Nov 12, 2026 | |
| Geode Capital | 2.13M | −11,295 | Nov 6, 2026 | |
| BNP Paribas | 1.75M | −6,809 | Nov 12, 2026 |